Frankfurt
23.12.24
08:16 Uhr
0,001 Euro
+0,000
+66,67 %
+66,67 %
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 03.12. | Episurf Medical to present at Redeye Technology & Life Science Day on December 3rd, 2024 | 1 | Cision News | ||
| 11.11. | Episurf Medical to present at Redeye Medtech & Diagnostics Event on November 13th, 2024 | 2 | Cision News | ||
| 25.10. | Episurf Medical AB: Interim Report 1 January - 30 September 2024 | 63 | GlobeNewswire (Europe) | Improvement of financial result through lower cost base and increased revenues
Focus towards expansion of US sales force
Continued progress of 510(k)-process for great toe implant
"I am pleased... ► Artikel lesen | |
| 01.10. | Members of the Nomination Committee for Episurf Medical's Annual General Meeting in 2025 | 2 | Cision News | ||
| 24.09. | Niles Noblitt, through Sacajo Investments LLC, makes investment in Episurf through an arrangement with CEO Pål Ryfors | 4 | Cision News | ||
| 24.09. | Episurf Medical: Update on 510(k) application for big toe implant | 2 | Cision News | ||
| EPISURF MEDICAL Aktie jetzt für 0€ handeln | |||||
| 19.09. | Episurf Medical to present at Pareto Securities Healthcare Conference on September 19, 2024 | 1 | Cision News | ||
| 27.08. | EPISURF: Episealer® technology to be presented at international scientific congress | 3 | Cision News | ||
| 12.07. | EPISURF: INTERIM REPORT 1 JANUARY - 30 JUNE 2024 | 3 | Cision News | ||
| 12.07. | Episurf Medical AB: Interim Report 1 January - 30 June 2024 | 102 | GlobeNewswire (Europe) | 45% sales growth despite transformation of sales organization
Additional SEK 12m in annual cost savings identified
Pause of EPIC-Knee trial to the advantage of other initiatives
"We have started... ► Artikel lesen | |
| 27.06. | Nasdaq Stockholm AB: New equity right for trading, Episurf Medical AB TO 13 | 269 | GlobeNewswire | At the request of Episurf Medical AB , Episurf Medical AB equity rights will be
traded on First North Growth Market as from June 28, 2024.
Security name: Episurf Medical AB TO 13
----------------------------------------
Short... ► Artikel lesen | |
| 27.05. | Nasdaq Stockholm AB: Listing of unit rights and paid subscription units of Episurf Medical AB | 398 | GlobeNewswire | With effect from May 28, 2024, the unit rights in Nasdaq will be traded on the
list for Equity rights. Trading will continue up until and including June 07,
2024.
Instrument: Unit rights ... ► Artikel lesen | |
| 24.05. | Episurf Medical AB: Episurf Medical publishes prospectus in connection with the company's partially guaranteed rights issue of up to approximately SEK 120 million | 362 | GlobeNewswire (Europe) | THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, BELARUS, HONG KONG, JAPAN, CANADA... ► Artikel lesen | |
| 22.05. | Episurf Medical AB: Summary From The Extraordinary General Meeting Of Episurf Medical AB (publ) | 111 | GlobeNewswire (Europe) | Episurf Medical AB (publ) held an Extraordinary General Meeting in Stockholm today 22 May 2024 at which it was resolved, among other things, to approve the Board of Directors' resolution on a rights... ► Artikel lesen | |
| 22.05. | XFRA CAPITAL ADJUSTMENT INFORMATION - 22.05.2024 | 941 | Xetra Newsboard | Das Instrument A07 BMG067231032 AVANCE GAS HLDG DL 2 EQUITY wird cum Kapitalmassnahme gehandelt am 22.05.2024 und ex Kapitalmassnahme am 23.05.2024 The instrument A07 BMG067231032 AVANCE GAS HLDG DL... ► Artikel lesen | |
| 24.04. | Episurf Medical AB: Interim report 1 January - 31 March 2024 | 226 | GlobeNewswire (Europe) | • Reduced cost base following implementation of restructuring programme
• Ongoing regulatory process targeting 510(k)-clearance Episealer® MTP-System
• Largest distribution agreement to date in the... ► Artikel lesen | |
| 09.02. | Episurf Medical AB: Year-End Report 1 January - 31 December 2023 | 113 | GlobeNewswire (Europe) | Continued stable growth despite restructuring of commercial organization, and satisfactory start in the US with significant opportunities ahead
Restructuring program completed with planned cost... ► Artikel lesen |
17 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| IMUNON | 0,780 | +6,85 % | Imunon, Inc.: IMUNON Announces Positive CMC Meeting with FDA for IMNN-001 in Treatment of Advanced Ovarian Cancer | Company aligned with FDA on CMC strategy and requirements in preparation of Phase 3 pivotal trial of IMNN-001 Vertical integration of major components assures a high-quality, commercially viable future... ► Artikel lesen | |
| ELECTROCORE | 14,500 | +0,69 % | Q2 Earnings Forecast for electroCore Issued By HC Wainwright |
EPISURF MEDICAL AB gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell +66,67 % bei einem Aktienkurs von 0,001 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu EPISURF MEDICAL AB finden Sie auf Wallstreet Online.
